Talphera, Inc. fell 12.5% on Friday, November 13, 2026, on 1,219,598 shares, 7.8 times its average daily volume. Headlines around the move:
Talphera, Inc. (TLPH:NASDAQ) closed at $0.906 on November 13, 2026, down 12.46% on the day. The stock trades 42.3% below its 52-week high of $1.57 and 31.3% above its 52-week low of $0.690. Over the past year, it lost 31.4%. Talphera, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, TLPH closed higher on 104 days (41%). Its best day was February 23, 2026 (+20.51%) and its worst was November 13, 2025 (-18.60%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.
Find more stocks like TLPH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.